(NASDAQ: PROK) Prokidney's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.09%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.05%.
Prokidney's earnings in 2026 is -$103,282,000.On average, 8 Wall Street analysts forecast PROK's earnings for 2026 to be -$176,863,063, with the lowest PROK earnings forecast at -$195,580,491, and the highest PROK earnings forecast at -$161,925,407. On average, 8 Wall Street analysts forecast PROK's earnings for 2027 to be -$178,012,114, with the lowest PROK earnings forecast at -$231,140,581, and the highest PROK earnings forecast at -$133,350,335.
In 2028, PROK is forecast to generate -$132,624,619 in earnings, with the lowest earnings forecast at -$162,983,743 and the highest earnings forecast at -$117,475,295.